TRIDENT LIFELINE Financial Statement Analysis
|
||
|
The Revenues of TRIDENT LIFELINE have increased by 48.36% YoY .
The Earnings Per Share (EPS) of TRIDENT LIFELINE has increased by 56.16 % YoY. |
||
TRIDENT LIFELINE Last 5 Annual Financial Results
[BOM: 543616]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹129 Cr | ₹87 Cr | ₹45 Cr | ₹32 Cr | ₹22 Cr |
| Expenses | ₹101 Cr | ₹72 Cr | ₹36 Cr | ₹25 Cr | ₹19 Cr |
| Operating Profit (Excl OI) | ₹28 Cr | ₹15 Cr | ₹8.23 Cr | ₹6.27 Cr | ₹2.71 Cr |
| Other Income | ₹10 Cr | ₹8.23 Cr | ₹2.08 Cr | ₹1.16 Cr | ₹0.60 Cr |
| Interest | ₹5.32 Cr | ₹4.14 Cr | ₹0.65 Cr | ₹0.48 Cr | ₹0.13 Cr |
| Depreciation | ₹6.07 Cr | ₹5.49 Cr | ₹0.97 Cr | ₹0.37 Cr | ₹0.20 Cr |
| Profit Before Tax | ₹27 Cr | ₹14 Cr | ₹8.70 Cr | ₹6.58 Cr | ₹2.98 Cr |
| Profit After Tax | ₹19 Cr | ₹10 Cr | ₹5.94 Cr | ₹6.02 Cr | ₹3.95 Cr |
| Consolidated Net Profit | ₹19 Cr | ₹12 Cr | ₹6.34 Cr | ₹6.02 Cr | ₹3.95 Cr |
| Earnings Per Share (Rs) | ₹15.96 | ₹10.22 | ₹5.52 | ₹5.23 | ₹4.93 |
| PAT Margin (%) | 14.97 | 12.07 | 13.31 | 18.99 | 18.14 |
| ROE(%) | 24.83 | 18.78 | 12.52 | 24.21 | 83.23 |
| ROCE(%) | 22.71 | 19.17 | 15.32 | 23.60 | 43.21 |
| Total Debt/Equity(x) | 0.78 | 0.87 | 0.37 | 0.17 | 0.52 |
Key Financials |
||
| Market Cap | : | ₹ 509.2 Cr |
| Revenue (TTM) | : | ₹ 137.9 Cr |
| Net Profit(TTM) | : | ₹ 21.4 Cr |
| EPS (TTM) | : | ₹ 17.8 |
| P/E (TTM) | : | 23.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| TRIDENT LIFELINE | 1.5% | 14.7% | 39.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 7.3% | 8.4% | 13.1% |
| DIVIS LABORATORIES | 15.3% | 24.1% | 63% |
| TORRENT PHARMACEUTICALS | 1% | 2.5% | 33.4% |
| CIPLA | 0.4% | 7.9% | -6.2% |
| DR REDDYS LABORATORIES | 1% | 15.9% | 14% |
| MANKIND PHARMA | 5.1% | 12.3% | 8.8% |
| LUPIN | -0.2% | 2.7% | -0.2% |
| ZYDUS LIFESCIENCES | 1.9% | 8.8% | 23.4% |
TRIDENT LIFELINE Revenues
[BOM: 543616]
| Y-o-Y | 48.36 % |
| 5 Yr CAGR | 56.03 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹129 Cr | 48.36 | |
| Mar2025 | ₹87 Cr | 94.86 | |
| Mar2024 | ₹45 Cr | 40.82 | |
| Mar2023 | ₹32 Cr | 45.59 | |
| Mar2022 | ₹22 Cr | - | |
TRIDENT LIFELINE Operating Profit
[BOM: 543616]
| Y-o-Y | 87.36 % |
| 5 Yr CAGR | 79.51 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹28 Cr | 87.36 | |
| Mar2025 | ₹15 Cr | 82.35 | |
| Mar2024 | ₹8.23 Cr | 31.41 | |
| Mar2023 | ₹6.27 Cr | 131.30 | |
| Mar2022 | ₹2.71 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 26.23 % |
| 5 Yr CAGR | 15.06 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 21.8% | 26.23 | |
| Mar2025 | 17.27% | -6.40 | |
| Mar2024 | 18.45% | -6.68 | |
| Mar2023 | 19.77% | 58.92 | |
| Mar2022 | 12.44% | - | |
TRIDENT LIFELINE Profit After Tax
[BOM: 543616]
| Y-o-Y | 62.08 % |
| 5 Yr CAGR | 48.19 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | 62.08 | |
| Mar2025 | ₹12 Cr | 85.18 | |
| Mar2024 | ₹6.34 Cr | 5.47 | |
| Mar2023 | ₹6.02 Cr | 52.36 | |
| Mar2022 | ₹3.95 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 24.03 % |
| 5 Yr CAGR | -4.69 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 14.97 % | 24.03 | |
| Mar2025 | 12.07 % | -9.32 | |
| Mar2024 | 13.31 % | -29.91 | |
| Mar2023 | 18.99 % | 4.69 | |
| Mar2022 | 18.14 % | - | |
TRIDENT LIFELINE Earnings Per Share (EPS)
[BOM: 543616]
| Y-o-Y | 56.16 % |
| 5 Yr CAGR | 34.14 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹16 | 56.16 | |
| Mar2025 | ₹10 | 85.14 | |
| Mar2024 | ₹5.52 | 5.54 | |
| Mar2023 | ₹5.23 | 6.09 | |
| Mar2022 | ₹4.93 | - | |
TRIDENT LIFELINE Return on Capital Employed (ROCE)
[BOM: 543616]
| Y-o-Y | 18.47 % |
| 5 Yr CAGR | -14.86 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 22.71% | 18.47 | |
| Mar2025 | 19.17% | 25.13 | |
| Mar2024 | 15.32% | -35.08 | |
| Mar2023 | 23.6% | -45.38 | |
| Mar2022 | 43.21% | - | |
TRIDENT LIFELINE Share Price vs Sensex
| Current Share Price | : | ₹424.4 |
| Current MarketCap | : | ₹ 509.2 Cr |
| Updated EOD on | : | Nov 09,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 1.5% |
14.7% |
39.1% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
TRIDENT LIFELINE related INDICES
You may also like the below Video Courses
FAQ about TRIDENT LIFELINE Financials
How the annual revenues of TRIDENT LIFELINE have changed ?
The Revenues of TRIDENT LIFELINE have increased by 48.36% YoY .
How the Earnings per Share (EPS) of TRIDENT LIFELINE have changed?
The Earnings Per Share (EPS) of TRIDENT LIFELINE has increased by 56.16 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs